Full Text (PDF)
Review Article

Gestational Diabetes Mellitus

Simrat Kaur, Ritu null, S.P. Subashini null, Sanathoi Chanu null

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator



Journal of Nurse Midwifery and Maternal Health 9(1):p 27-29, January-April 2023. | DOI: 10.21088/jnmmh.2454.7506.9123.4

How Cite This Article:

Ritu, Subashini SP, Chanu S, et al. Gestational diabetes mellitus. J Nurse Midwifery Matern Health. 2023;9(1):27–9.

Timeline

Received : March 24, 2023         Accepted : April 14, 2023          Published : May 30, 2023

Abstract

Gestational diabetes mellitus (GDM) is increasing in prevalence in tandem with the dramatic increase in the prevalence of overweight and obesity in women of childbearing age. Much controversy surrounds the diagnosis and management of gestational diabetes, emphasizing the importance and relevance of clarity and consensus. If newly proposed criteria are adopted universally a significantly growing number of women will be diagnosed as having GDM, implying new therapeutic challenges to avoid foetal and maternal complications related to the hyperglycemia of gestational diabetes. This review provides an overview of clinical issues related to GDM, including the challenges of screening and diagnosis, the pathophysiology behind GDM, the treatment and prevention of GDM and the long and short term consequences of gestational diabetes for both mother and offspring.


References

  • 1.   Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabet Med. 2004;21(2):103–13.
  • 2.   Catalano PM, Ehrenberg HM. The short- and long-term implications of maternal obesity on the mother and her offspring. BJOG. 2006;113(10):1126–33.
  • 3.   HAPO Study Cooperative Research Group. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Int J Gynaecol Obstet. 2002;78(1):69–77.
  • 4.   Ferrara A. Increasing prevalence of gestational diabetes mellitus: A public health perspective. Diabetes Care. 2007;30 Suppl 2:S141–6.
  • 5.   Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG. Gestational diabetes mellitus: Results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med. 2012;25(6):600–10.
  • 6.   Macaulay S, Dunger DB, Norris SA. Gestational diabetes mellitus in Africa: A systematic review. PLoS One. 2014;9(6):e97871.
  • 7.   International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels: International Diabetes Federation; 2013.
  • 8.   American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care. 2014;37 Suppl 1:S14–80.
  • 9.   Nielsen LR, Ekbom P, Damm P, Glümer C, Frandsen MM, Jensen DM, et al. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care. 2004;27(5):1200–1.
  • 10.   Yogev Y, Metzger BE, Hod M. Establishing diagnosis of gestational diabetes mellitus: Impact of the hyperglycemia and adverse pregnancy outcome study. Semin Fetal Neonatal Med. 2009;14(2):94–100.

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

Whether all authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

The authors report no conflicts of interest in this work.


About this article


Cite this article

Ritu, Subashini SP, Chanu S, et al. Gestational diabetes mellitus. J Nurse Midwifery Matern Health. 2023;9(1):27–9.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator



Received Accepted Published
March 24, 2023 April 14, 2023 May 30, 2023

DOI: 10.21088/jnmmh.2454.7506.9123.4

Keywords

Gestational diabetesDiagnostic criteriaComplicationsTreatment

Article Level Metrics

Last Updated

Tuesday 28 July 2026, 20:56:33 (IST)


1015

Accesses

15
120
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received March 24, 2023
Accepted April 14, 2023
Published May 30, 2023

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator



Access this article



Share